Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

Core Insights - Bionano Genomics showcased its advancements in optical genome mapping (OGM) at the 2026 ACMG Annual Meeting, with a significant increase in studies presented, highlighting the growing importance of OGM in genomics research [1][5] Group 1: Event Participation and Presentations - Bionano Genomics participated in the 2026 ACMG Annual Meeting held from March 14-18 in Baltimore, Maryland, presenting twelve studies, which is a two-fold increase from 2025 [1] - The studies included four oral presentations and eight poster presentations, focusing on the application of OGM in detecting structural variants (SVs) in cancer genomics and genetic disorders [1][2] Group 2: Applications and Impact of OGM - The studies demonstrated OGM's capability to identify SVs that may be overlooked by other techniques, particularly in areas such as hematologic malignancies and rare diseases [1][5] - A workshop titled "Ask the OGM Expert" was conducted by Nikhil Sahajpal, PhD, allowing attendees to gain insights on OGM applications [1] - Baylor Genetics announced the commercial release of a service providing OGM data to the research community, further enhancing the accessibility of this technology [1] Group 3: Industry Perspective - Erik Holmlin, CEO of Bionano, emphasized the increasing application of OGM and its potential to aid researchers in exploring complex genomic variations, positioning OGM as a central technique in modern cytogenetics [5]